Evidence map›Paper›PMID 30059559›Full record

ArticlePloS one2018

Streptococcus pneumoniae potently induces cell death in mesothelial cells.

Rabab Rashwan, Julius F Varano Della Vergiliana, Sally M Lansley, Hui Min Cheah, Natalia Popowicz, James C Paton, Grant W Waterer, Tiffany Townsend, Ian Kay, Jeremy S Brown and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Pneumolysin: Pathogenesis and Therapeutic Target.Frontiers in microbiology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Rabab RashwanCentre for Respiratory Health, University of Western Australia, Perth, Western Australia, Australia.
Julius F Varano Della VergilianaCentre for Respiratory Health, University of Western Australia, Perth, Western Australia, Australia.
Sally M LansleyCentre for Respiratory Health, University of Western Australia, Perth, Western Australia, Australia.ORCID 0000-0001-7157-8094
Hui Min CheahCentre for Respiratory Health, University of Western Australia, Perth, Western Australia, Australia.
Natalia PopowiczCentre for Respiratory Health, University of Western Australia, Perth, Western Australia, Australia.
James C PatonResearch Centre for Infectious Diseases, Department of Molecular and Cellular Biology, University of Adelaide, Adelaide, South Australia, Australia.
Grant W WatererRespiratory Department, Royal Perth Hospital, Perth, Western Australia, Australia.
Tiffany TownsendDept of Microbiology & Infectious Diseases, Royal Perth Hospital, Perth, Western Australia, Australia.
Ian KayDept of Microbiology & Infectious Diseases, Royal Perth Hospital, Perth, Western Australia, Australia.
Jeremy S BrownCentre for Inflammation and Tissue Repair, UCL Respiratory, University College London, London, United Kingdom.
Y C Gary LeeCentre for Respiratory Health, University of Western Australia, Perth, Western Australia, Australia.
The University of Western Australia · AURoyal Perth Hospital · AUCentre for Inflammation Research · GBThe University of Adelaide · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pleural infection/empyema is common and its incidence continues to rise. Streptococcus pneumoniae is the commonest bacterial cause of empyema in children and among the commonest in adults. The mesothelium represents the first line of defense against invading microorganisms, but mesothelial cell responses to common empyema pathogens, including S. pneumoniae, have seldom been studied. We assessed mesothelial cell viability in vitro following exposure to common empyema pathogens. Clinical isolates of S. pneumoniae from 25 patients with invasive pneumococcal disease and three reference strains were tested. All potently induced death of cultured mesothelial cells (MeT-5A) in a dose- and time-dependent manner (>90% at 107 CFU/mL after 24 hours). No significant mesothelial cell killing was observed when cells were co-cultured with Staphylococcus aureus, Streptococcus sanguinis and Streptococcus milleri group bacteria. S. pneumoniae induced mesothelial cell death via secretory product(s) as cytotoxicity could be: i) reproduced using conditioned media derived from S. pneumoniae and ii) in transwell studies when the bacteria and mesothelial cells were separated. No excess cell death was seen when heat-killed S. pneumoniae were used. Pneumolysin, a cytolytic S. pneumoniae toxin, induced cell death in a time- and dose-dependent manner. S. pneumoniae lacking the pneumolysin gene (D39 ΔPLY strain) failed to kill mesothelial cells compared to wild type (D39) controls, confirming the necessity of pneumolysin in D39-induced mesothelial cell death. However, pneumolysin gene mutation in other S. pneumoniae strains (TIGR4, ST3 and ST23F) only partly abolished their cytotoxic effects, suggesting different strains may induce cell death via different mechanisms.

Indexed as

Bacterial ProteinsCell DeathCells, CulturedCell SurvivalChildEmpyema, PleuralEpithelial CellsEpitheliumHumansPleuraPneumococcal InfectionsStreptococcus pneumoniaeStreptolysinsBacterial ProteinsplY protein, Streptococcus pneumoniaeStreptolysins

Identifiers

PMID30059559
PMCPMC6066251
OpenAlexW2887842196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.